Skip to search formSkip to main contentSkip to account menu

Flavoxate

Known as: 2-Piperidinoethyl 3-methylflavone-8-carboxylate, 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester, 2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate 
A synthetic parasympatholytic with antimuscarinic, muscle relaxant and urinary antispasmodic properties. Flavoxate binds and inhibits muscarinic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
BACKGROUND Chronic radiation cystitis occurs a minimum of three months after completion of pelvic radiotherapy and represents a… 
Review
2000
Review
2000
  • J. Nickel
  • 2000
  • Corpus ID: 16018712
OBJECTIVE To review current knowledge about the epidemiology, etiology, diagnosis, and treatment of interstitial cystitis, with… 
1996
1996
Background: This study was designed to clarify the primary site of action of flavoxate, clinically used for the treatment of… 
1995
1995
To investigate the effect of flavoxate (Urispadol) treatment on patients with symptomatic benign prostatic hypertrophy (BPH… 
Highly Cited
1990
Highly Cited
1990
Detrusor instability occurs in approximately 10% of the adult population, producing troublesome symptoms. The pharmacotherapy… 
Highly Cited
1983
Highly Cited
1983
In a randomised double-blind cross-over trial of 19 females with motor urge incontinence but without bladder suspension defect… 
1979
1979
The effect of Flavoxate on hyperactive detrusor contraction was studied in 37 patients, including 11 patients in whom the drug… 
1977
1977
Flavoxate, a smooth muscle relaxant, compared with propantheline showed no significant difference in clinical effect on voiding…